Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
Chonnam Medical Journal · 2023 · 59 (2) · 115
DOI: 10.4068/cmj.2023.59.2.115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chonnam Medical Journal, 2023. Verfasst von Naina Mohamed Pakkir Maideen. Beteiligte Einrichtung: Dubai Academic Health Corporation, Dubai, UAE. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Proton Pump Inhibitors are used widely to manage many gastric acid-related conditions such as gastroesophageal disease, gastritis, esophagitis, Barrett's esophagus, Zollinger-Ellison syndrome, peptic ulcer disease, nonsteroidal anti-inflammatory drug-associated ulcers, and Helicobacter pylori eradication, around the globe. This review article focuses on adverse effects associated with the long-term use of proton pump inhibitors. Various observational studies, clinical trials, and meta-analyses have established the adverse effects associated with the long-term use of proton pump inhibitors including renal disorders (acute interstitial nephritis, acute kidney injury, chronic kidney disease, and end-stage renal disease), cardiovascular risks (major adverse cardiovascular events, myocardial infarction, stent thrombosis, and stroke), fractures, infections (Clostridium difficile infection, community-acquired pneumonia, and Coronavirus disease 2019), micronutrient deficiencies (hypomagnesemia, anemia, vitamin B12 deficiency, hypocalcemia, hypokalemia), hypergastrinemia, cancers (gastric cancer, pancreatic cancer, colorectal cancer, hepatic cancer), hepatic encephalopathy, and dementia. Clinicians including prescribers and pharmacists should be aware of the adverse effects of taking proton pump inhibitors for an extended period of time. In addition, the patients taking proton pump inhibitors for long-term should be monitored for the listed adverse effects. The American Gastroenterological association recommends a few non-pharmacological measures and the use of histamine 2 blockers to lessen gastrointestinal symptoms of gastroesophageal reflex disease and the utilization of proton pump inhibitors treatment if there is a definitive indication. Additionally, the American Gastroenterological association's Best Practice Advice statements emphasize deprescribing when there is no clear indication for proton pump inhibitors therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dubai Academic Health Corporation, Dubai, UAE.
Zitieren
APA
Maideen, N. M. P. (2023). Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal, 59(2), 115. https://doi.org/10.4068/cmj.2023.59.2.115
Vancouver
Maideen NMP. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal. 2023;59(2):115. doi:10.4068/cmj.2023.59.2.115
BibTeX
@article{Maideen2023,
author = {Maideen, Naina Mohamed Pakkir},
title = {Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors},
journal = {Chonnam Medical Journal},
year = {2023},
volume = {59},
number = {2},
pages = {115},
doi = {10.4068/cmj.2023.59.2.115}
}
EUVIMED